These drugs function by mimicking the natural hormone GLP-1, which is released by intestinal L cells in response to food intake
Kelly AS, Metzig AM, Rudser KD, Fitch AK, Fox CK, Nathan BM et al
Many studies only report superficial phenotypic changes, such as Th17/Treg ratios or related cytokines, which greatly reduces the comparability and reproducibility of the research
Combination Procedures: Maximizing Results Many post-GLP-1 patients benefit from combination procedures that address multiple areas simultaneously
Effects include: Appetite suppression acts on hypothalamic hunger centers Delayed gastric emptying food stays in the stomach longer, increasing satiety Improved insulin sensitivity reduces blood sugar spikes Reduced food reward signaling decreases cravings and reward-driven eating Semaglutide is a single agonist it targets only the GLP-1 receptor
In fact, it represents one of modern medicine's oldest and most persistent challenges